Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests

Core Viewpoint - Exact Sciences Corp. celebrates the passage of federal legislation that will enable Medicare coverage for multi-cancer early detection (MCED) tests, addressing a significant gap in cancer screening [1] Group 1: Legislative Impact - The new legislation establishes a pathway for Medicare to cover MCED tests, which is crucial for early cancer detection [1] - Nearly 70% of annual cancer cases and deaths in the U.S. occur in cancers that currently have no recommended screening [1] Group 2: Industry Context - Cancer remains the second leading cause of death in the U.S., highlighting the urgent need for improved screening methods [1]